Work

Drug-eluting stents.

Year: 2010

Type: article

Abstract: Coronary artery disease (CAD) is currently a leading cause of death worldwide. Drug-eluting stents (DESs) have been dominant for the treatment of CAD in the interventional cardiology world owing to their efficacy in significantly reducing restenosis. However, late stage stent thrombosis has become a major concern. Stent platform, drug delivery vehicle and type of drug are three parts of DES and each part affects the performance of the DES. Aiming to provide a clue for the design of future DES, this review focuses on the development of the three major components of DES and their roles in restenosis and thrombosis.

Source: PubMed

Authors: Xiaodong Ma, Tim Wu, Michael P Robich, Xingwei Wang, Hao Wu, Bryan Buchholz, Stephen McCarthy

Language: English

Topic: Coronary Interventions and Diagnostics

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Heart, Lung, and Blood Institute

Award: Novel Biodegradable Polymer and Its Coated Drug Eluting Stent

OpenAlex ID: W3151249172

FWCI: 1.284

Cites: 99

Cited by: 12

Related to: 10